The American Journal of Managed Care > November 2008

The American Journal of Managed Care - November 2008

November 14, 2008 – Teisha A. Robertson, PharmD, MBA; Catherine E. Cooke, PharmD, BCPS; Jingshu Wang, PhD; Fadia T. Shaya, PhD, MPH; and Helen Y. Lee, PharmD, MBA

This study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.

November 15, 2008 – Salvatore A. Ferro, PharmD (Cand); Brian S. Myer, BS; Debra A. Wolff, MS; Marek S. Poniewierski, MD, MS; Eva Culakova, PhD; Leon E. Cosler, PhD, RPh; Sarah L. Scarpace, PharmD; Alok A. Khorana, MD; and Gary H. Lyman, MD, MPH, FRCP(Edin)
Using data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.
November 15, 2008 – Pierre-Yves Cr??mieux, PhD; Henry Buchwald, MD, PhD; Scott A. Shikora, MD; Arindam Ghosh, PhD; Haixia Elaine Yang, PhD; and Marric Buessing, BA
November 15, 2008 – Judith H. Hibbard, DrPH; Jessica Greene, PhD; and Martin Tusler, MS
Enrollment in a consumer-driven health plan does not appear to encourage enrollees to become active, informed managers of their own health and healthcare.
November 15, 2008 – Stephen N. Rosenberg, MD, MPH; Tatiana L. Shnaiden, MD, MS; Arnold A. Wegh, MS; and Iver A. Juster, MD
This study measured compliance with evidence-based guidelines after clinical alerts sent to physicians, compared with compliance after alerts sent to both physicians and their patients.
November 15, 2008 – Gregory D. Berg, PhD; Steven Silverstein, MD; Eileen Thomas, RN; and Allan M. Korn, MD
By mailing information to their members, health plans can affect rates of medical service utilization and generate cost savings.
November 15, 2008 – Kiran E. Laxman, BSc; Kate S. Lovibond, BSc, MSc; and Miriam K. Hassan, BPharm, PhD
This systematic review examines the impact of bipolar disorder on employee attendance and functioning at work, along with the associated economic burden to US employers.
November 15, 2008 – Diana I. Brixner, PhD, RPh; and Carrie McAdam-Marx, RPh, MS
This review shows that insulin analogs are cost-effective versus human insulins based on pharmacoeconomic models and retrospective database analyses.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.